Pesquisa

Edição
Título
Autores
Nº 2 (2013)
Kidney in patients survived in hantaan and puumala virus-induced nephropathy
Sirotin B.
PDF
(Rus)
Volume 13, Nº 3 (2021)
Indicators of endogenous intoxication and lipid peroxidation in the dynamics of treatment with α-lipoic acid in men with diabetic nephropathy at the stage of microalbuminuria
Darenskaya M., Chugunova E., Kolesnikov S., Grebenkina L., Semenova N., Nikitina O., Kolesnikova L.
PDF
(Rus)
Nº 1 (2017)
Insulin resistance as a risk factor for the development of uric acid nephrolithiasis
Perfil'ev V., Zverev Y., Zharikov A.
PDF
(Rus)
Nº 5 (2014)
Peculiarities of functioning of the kidneys in overweight patients with essential hypertension
Krutikov E., Chistyakova S.
PDF
(Rus)
Nº 5 (2011)
SUCCESFUL RITUXIMAB THERAPY OF MEMBRANOUS NEPHROPATHY, RESISTANT TO STANDARD IMMUNOSUPRESSIVE TREATMENT
Pulin A., Gornostaeva E., Roshchupkina S., Kozlovskaya L., Fomin V., Mukhin N.
Nº 2 (2011)
NEPHROPATHY IN HEROIN AND COCAINE ABUSERS
Nº 2 (2010)
Update on renal affection in obesity
Saginova E., Gallyamov M., Severova M., Saginova E., Gallyamov M., Severova M.
Volume 12, Nº 4 (2020)
Nephroprotective effects of sodium-glucose linked transporter-2 inhibitors
Daminov B., Abdullaev S., Sharapov O.
PDF
(Rus)
Nº 4 (2017)
Kidney damage in type 2 diabetes mellitus: is it diabethic nephropathy only?
Amosova M., Gurova O.
PDF
(Rus)
Nº 5 (2011)
OUTCOMES OF DYSMETABOLIC NEPHROPATHIES: RESULTS OF THE RETROSPECTIVE STUDY
Maksudova Adelya Nailevna -., Salikhov Il'dar Gazimdzhanovich -., Mal'tsev Stanislav Viktorovich -.
Nº 5 (2010)
Anaemia correction in diabetic nephropathy: target haemoglobin values and cardiovascular complications
Shestakova M., Martynov S.
Nº 2 (2010)
Early markers of diabetic nephropathy
Bondar' I., Klimontov V., Bondar I., Klimontov V.
Volume 17, Nº 1 (2025)
Clinical cases of acute kidney injury under conditions of exposure to short-term abnormal heat waves
Murkamilov I., Aitbaev K., Fomin V., Yusupov F., Yusupova T., Yusupova Z., Duysheeva G., Khakimov S., Solizhonov Z., Ymankulov D.
PDF
(Rus)
Volume 12, Nº 2 (2020)
Selective screening for Fabry disease: review of literature data and experience in the Russian Federation
Ilyushkina A., Baydakova G., Bychkov I., Buruleva N., Zakharova E.
PDF
(Rus)
Nº 4 (2017)
Analysis of the effect of markers of kidney injury related to the carbohydrate metabolism disorders on the risk of non-selective proteinuria
Ustinova M., Batiushin M.
PDF
(Rus)
Nº 5-6 (2012)
Diabetic nephropathy and anemia: treatment considerations
Demicheva T.
PDF
(Rus)
Nº 3 (2011)
Unresolved questions of diabetic nephropathy (part I)
Volkova N., Antonenko M.
Nº 6 (2010)
INFLAMMATORY CYTOKINES IN PATHOGENESIS, DIAGNOSIS AND TREATMENT OF DIABETIC NEPHROPATHY
Bondar' I., Klimontov V., Simakova A.
Nº 1 (2009)
Allopurinol: indications and tactics of prescription
Lebedeva M.
Volume 16, Nº 2 (2024)
Roxadustat: treatment of anemia and additional clinical effects (literature review)
Mikhailova N.
PDF
(Rus)
Volume 12, Nº 4 (2020)
Assessment of cardiovascular risk in type 1 diabetes mellitus taking into account various markers of kidney damage
Goldschmid A., Karamullina R., Chechikova E., Amosova M., Poluboyarinova I., Fadeev V.
PDF
(Rus)
Nº 3 (2017)
Urinary biomarker of podotsitarian dysfunction: importance for early diagnosis of kidney damage to type 2 diabetes mellitus
Yarkova N., Borovkov N.
PDF
(Rus)
Nº 2 (2013)
Sulodexide and chronic kidney disease: clinical and experimental studies
Svistunov A., Fomin V.
PDF
(Rus)
Nº 5 (2010)
Fabry disease with proteinuric nephropathy and hypertrophic cardiomyopathy, misinterpreted as chronic glomerulonephritis in Schonlein-Henoch purpura
Fomin V., Pulin A., Rameev V., Sedov V., Meshkov A., Roshchupkina S., Panasyuk V., Kozlovskaya L., Mukhin N.
Nº 6 (2010)
Hypertensive nephropathy evolution in patients with metabolic syndrome
Galushkin A., Batyushin M., Terent'ev V., Gorblyanskiy Y., Stepkova V., Volikov N.
Nº 2 (2009)
Membranous nephropathy: how to differentiate primary and paraneoplastic variants?
Mukhin N., Kozlovskaya L., Shilov E., Miroshnichenko N.
Volume 16, Nº 2 (2024)
External validity of the international method for predicting clinical outcome of immunoglobulin A-nephropathy in the Belarusian cohort of patients
Komissarov K., Krasko O., Pilotovich V., Dmitrieva M., Letkovskaya T., Prilutsky S.
PDF
(Rus)
Volume 12, Nº 2 (2020)
Histopatological spectrum of kidney diseases according to renal biopsies performed in Minsk, Republic of Belarus
Komissarov K., Komissarov K., Dmitrieva M., Letkovskaya T.
PDF
(Rus)
Nº 2 (2016)
Using different equations for estimating glomerular filtration rate in patients with type 1 diabetes
Kaplanyan M., Ryasnyanskii V., Vorokhobina N.
PDF
(Rus)
Nº 3 (2013)
Antioxidants in nephrology: bardoxolone and diabetic nephropathy
PDF
(Rus)
Nº 5 (2010)
INTRACELLULAR SIGNALLING PATHWAYS IN DIABETIC NEPHROPATHY: NEW TARGETS FOR NEPHROPROTECTION
Bondar' I., Klimontov V.
Nº 3 (2010)
Clinical variants of systemic amyloidosis with myocardial involvement and difficulties of its diagnosis
Voloshinova E., Grigor'eva E., Sazhnova S., Rebrov A., Voloshinova E., Grigorieva E., Sajnova S., Rebrov A.
Nº 4 (2009)
POTENTIALS OF ANGIOTENSIN II RECEPTOR BLOCKERS IN HALTING THE PROGRESSION OF RENAL TRANSPLANT NEPHROPATHY
Maksimov M.
Volume 14, Nº 4 (2022)
Therapy for immunoglobulin А-nephropathy: what along with immunosuppression?
Bobkova I., Kamyshova E.
PDF
(Rus)
Volume 11, Nº 3 (2019)
Clinical and genetic features of idiopathic membranous nephropathy in russian patients
Bobyleva I., Kakhsurueva P., Kamyshova E., Bobkova I., Li O., Kuchieva A., Filatova E., Zakharova E., Borisov A.
PDF
(Rus)
Nº 5-6 (2015)
Characteristic features of intrarenal blood flow in patients with essential hypertension and preclinical hypertensive nephropathy
Krutikov E., Chistjakova S., Cvetkov V.
PDF
(Rus)
Nº 5-6 (2012)
Urinary excretion of matrix metalloproteinases and their inhibitors in type 1 diabetic patients with nephropathy
Bondar I., Klimontov V., Romanov V.
PDF
(Rus)
Nº 5 (2010)
ANGIOTENSIN II RECEPTOR BLOCKER VALSARTAN AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR ENALAPRIL IN HYPERTENSIVE PATIENTS WITH RENAL TRANSPALANT NEPHROPATHY
Maksimov M.
Nº 4 (2010)
PRYaMOY INGIBITOR RENINA ALISKIREN - SAMOSTOYaTEL'NAYa STRATEGIYa KORREKTsII KARDIORENAL'NOGO SINDROMA PRI METABOLIChESKOM SINDROME I OZhIRENII
Fomin V., Saginova E.
Nº 4 (2009)
CLINICAL SIGNIFICANCE OF DETERMINATION OR URINARY CONCENTRATION OF ENDOTHELIAL DYSFUNCTION AND FIBROGENESIS MARKERS IN HYPERTENSIVE NEPHROPATHY
Nanchikeeva M., Kozlovskaya L., Fomin V., Bobkova I., Rameev V., Nanchikeeva M., Kozlovskaya L., Fomin V., Bobkova I., Rameev V.
Volume 14, Nº 3 (2022)
Iga-nephropathy in belarusian cohort. clinical and pathological peculiarities, factors, associated with unfavorable outcome
Komissarov K., Krasko O., Dmitrieva M., Letkovskaja T., Lugovskaya M., Kalinovskaya Y., Pilotovich V.
PDF
(Rus)
Nº 2 (2018)
Epigenetic regulation of renal fibrosis in diabetic nephropathy: focus on histone modifications
Aitbaev K., Murkamilov I., Murkamilova Z., Fomin V.
PDF
(Rus)
Nº 4 (2015)
Angiotensin converting enzyme gene polymorphism in children with reflux nephropathy
Zajkova N., Dulap D., Sakarje V., Ushurelu N., Dlin V., Korsunskij A., Stratulat P., Gackan S.
PDF
(Rus)
Nº 1 (2012)
SEVERE PODOCYTE DAMAGE IN ASYMPTOMATIC PATIENT WITH FABRY DISEASE
Fomin V., Pulin A., Aksenova O., Kustova T., Girina S., Roshchupkina S., Kudryavtsev V., Varshavskiy V., Golitsyna E., Damulin I., Panasyuk V., Mukhin N., Fomin V., Pulin A., Aksenova O., Kustova T., Girina S., Roschupkina S., Kudravtsev V., Varshavskii V., Golitsina E., Damulin I., Panasiuk V., Mukhin N.
Nº 6 (2010)
Parameters of oxidative metabolism of erythrocytes in diabetic nephropathy
Kurmanov M., Klyuev D.
Nº 4 (2010)
VICh-ASSOTsIIROVANNAYa NEFROPATIYa: STRATEGIYa DIAGNOSTIKI I LEChENIYa
Mukhin N., Fomin V.
Nº 1 (2009)
Atherosclerotic stenosis of the sole functioning kidney artery in patient with diabetes mellitus type 2 as a variant of kidney multimorbidity inelderly
Mukhin N., Shilov E., Fomin V., Moiseev S., Shvetsov M., Yurkevich L., Mukhin N., M Shilov E., Fomin V., Moiseev S., Shvetsov M., Yurkevich L.
Volume 13, Nº 2 (2021)
Assessment of the risk of developing complications of type 2 diabetes mellitus in the Azerbaijani population using various formulas to calculate the glomerular filtration rate
Akhmedova Z., Mekhtiev T.
PDF
(Rus)
Nº 2 (2018)
Early markers for the development and progression of reflux nephropathy in children
Zaykova N., Dlin V., Eremeeva A., Sinitsyna L., Korsunsky A., Revenko N.
PDF
(Rus)
Nº 1 (2014)
Bone mineral density, bone and phosphate-calcium metabolism parameters in patients with oxalate nephropathy in early stages of chronic kidney disease
Voronina N., Agievich T.
PDF
(Rus)
Nº 1 (2012)
Role of sulodexide in treatment of diabetic nephropathy in patients with type 1 diabetes mellitus
Aleksandrovich G., Andreeva E., Markova A., Morozova N., Saneeva G., Unanova I., Alexandrovich G., Andreeva E., Markov A., Morozova N., Saneeva G., Unanova I.
Nº 6 (2010)
Influence of obesity on kidney disease in patients with diabetes mellitus type 2
Savel'eva S., Kryachkova A., Zheleznyakova A., Vikulova O., Kutyrina I., Shestakova M.
Nº 1 (2010)
SH.I. RATNER AND HIS ROLE IN THE STUDY OF HEMORRHAGIC FEVER WITH RENAL SYNDROME ON RUSSIAN EAST (TO 110-TH ANNIVERSARY OF HIS BIRTH)
1 - 53 de 53 resultados
Dicas:
  • Palavras-chave são sensíveis a maiúsculas
  • Preposições e conjunções ingleses são ignoradas
  • Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
  • Use OR para pesquisar um termo exato, ex.: educação OR formação
  • Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
  • Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
  • Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
  • Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.